Literature DB >> 27627571

Clinical, Biochemical and Molecular Characteristics of the Main Types of Porphyria.

Urszula Szlendak1,2, Ksenia Bykowska2, Agnieszka Lipniacka2.   

Abstract

Porphyrias are diverse disorders that arise from various inherited enzyme defects in the heme biosynthesis pathway, except for porphyria cutanea tarda (PCT), in which the enzyme deficiency in most cases is acquired. The biosynthetic blocks resulting from the defective enzymes are largely expressed either in the liver or bone marrow, the sites where the majority of heme is produced. Although the pathophysiologic mechanisms of the clinical manifestations of the porphyrias are not fully understood, two cardinal features prevail: skin photosensitivity and neurologic symptoms of intermittent autonomic neuropathy, acute neurovisceral attacks, and disorders of the nervous system. The primary diagnosis of the proband is based on biochemical testing, which is not always able to identify acute porphyrias, especially in asymptomatic family carriers when heme precursors and porphyrins excretion is normal, low-normal and high-reduced values of enzyme activity overlap, and hematological diseases responsible for abnormal blood cells distribution coexist. Molecular analysis of gene mutations responsible for each type of porphyria is the best diagnostic approach for symptomatic as well as presymptomatic gene carriers.

Entities:  

Keywords:  acute hepatic porphyrias; erythropoietic porphyrias; porphyria cutanea tarda

Mesh:

Substances:

Year:  2016        PMID: 27627571     DOI: 10.17219/acem/58955

Source DB:  PubMed          Journal:  Adv Clin Exp Med        ISSN: 1899-5276            Impact factor:   1.727


  9 in total

Review 1.  Psychiatric Aspects of Acute Porphyria: a Comprehensive Review.

Authors:  Laura Duque-Serrano; Liliana Patarroyo-Rodriguez; Dorothy Gotlib; Juan C Molano-Eslava
Journal:  Curr Psychiatry Rep       Date:  2018-02-02       Impact factor: 5.285

2.  Detecting rare diseases in electronic health records using machine learning and knowledge engineering: Case study of acute hepatic porphyria.

Authors:  Aaron M Cohen; Steven Chamberlin; Thomas Deloughery; Michelle Nguyen; Steven Bedrick; Stephen Meninger; John J Ko; Jigar J Amin; Alex J Wei; William Hersh
Journal:  PLoS One       Date:  2020-07-02       Impact factor: 3.240

3.  Acute intermittent porphyria (AIP) in a patient with celiac disease.

Authors:  Sebastian Nunnemann; Christoph Uibel; Petra Budig; Mathias Mäurer
Journal:  Neurol Res Pract       Date:  2020-01-20

4.  Patient and caregiver experiences of living with acute hepatic porphyria in the UK: a mixed-methods study.

Authors:  Liz Gill; Sue Burrell; John Chamberlayne; Stephen Lombardelli; Jordanna Mora; Nicola Mason; Marieke Schurer; Madeline Merkel; Stephen Meninger; John J Ko
Journal:  Orphanet J Rare Dis       Date:  2021-04-26       Impact factor: 4.123

5.  Diagnosis of acute intermittent porphyria in a renal transplant patient: A case report.

Authors:  Cristina Sirch; Niloufar Khanna; Lynda Frassetto; Francesco Bianco; Mary Louise Artero
Journal:  World J Transplant       Date:  2022-01-18

6.  Porphyria and kidney diseases.

Authors:  Nicolas Pallet; Alexandre Karras; Eric Thervet; Laurent Gouya; Zoubida Karim; Hervé Puy
Journal:  Clin Kidney J       Date:  2018-01-10

Review 7.  Acute Intermittent Porphyria: Current Perspectives And Case Presentation.

Authors:  Zachary Spiritos; Shakirat Salvador; Diana Mosquera; Julius Wilder
Journal:  Ther Clin Risk Manag       Date:  2019-12-16       Impact factor: 2.423

Review 8.  Kidney Involvement in Acute Hepatic Porphyrias: Pathophysiology and Diagnostic Implications.

Authors:  Andrea Ricci; Claudio Carmine Guida; Paola Manzini; Chiara Cuoghi; Paolo Ventura
Journal:  Diagnostics (Basel)       Date:  2021-12-10

Review 9.  Cutting-Edge Therapies and Novel Strategies for Acute Intermittent Porphyria: Step-by-Step towards the Solution.

Authors:  Miriam Longo; Erika Paolini; Marica Meroni; Paola Dongiovanni
Journal:  Biomedicines       Date:  2022-03-11
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.